Inventor · disambiguated record
Chuo Chen
Also filed as: CHEN CHUO · CHEN CHUO-HSING
24 granted patents·10 pending applications·42 citations·filing 2001–2024
94Inventor score
Top patents by PatentIndex Score
34 records- 0193US11033635B2Antibody-STING agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·3 cites·28 claims
- 0292US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 0391US10633411B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 0490US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 0587US11597707B2CGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·26 claims
- 0686US11492368B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2020·Granted Nov 8, 2022·1 cites·15 claims
- 0786US10519188B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·21 claims
- 0886US10508129B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Dec 17, 2019·3 cites·15 claims
- 0984US10336786B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2013·Granted Jul 2, 2019·4 cites·17 claims
- 1084US2025115564A1cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1183US9783550B2Highly potent inhibitors of porcupineUNIV TEXAS·Filed 2014·Granted Oct 10, 2017·3 cites·19 claims
- 1282US2025115579A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1380US12134609B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Nov 5, 2024·0 cites·23 claims
- 1480US12065416B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·32 claims
- 1579US8445491B2Wnt protein signalling inhibitorsLUM LAWRENCE·Filed 2009·Granted May 21, 2013·6 cites·11 claims
- 1677US10696710B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Jun 30, 2020·0 cites·16 claims
- 1777US7484970B1Electrical connection socket structureSURTEC IND INC·Filed 2008·Granted Feb 3, 2009·6 cites·16 claims
- 1876US12091387B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 1975US12281078B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·26 claims
- 2072US12311030B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted May 27, 2025·0 cites·17 claims
- 2171US11213592B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 4, 2022·0 cites·26 claims
- 2270US2022340613A1Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2362US2025170120A1Allosteric sting modulators and methods of useUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2460US2017296655A1Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2017·Application pending·0 cites
- 2559US11299512B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·0 cites·34 claims
- 2656US9045416B2WNT protein signalling inhibitorsUNIV TEXAS·Filed 2013·Granted Jun 2, 2015·0 cites·6 claims
- 2747US2022098196A1Trapping-free parp inhibitorsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2847US2015157633A1Wnt protein signalling inhibitorsUNIV TEXAS·Filed 2013·Application pending·0 cites
- 2942US2007264623A1NanosensorsHARVARD COLLEGE·Filed 2005·Application pending·0 cites
- 3042US2015374696A1Wnt protein signalling inhibitorsUNIV TEXAS·Filed 2015·Application pending·0 cites
- 3141US11013704B2Compounds supports hematopoietic stem cells and red blood cellsUNIV TEXAS·Filed 2015·Granted May 25, 2021·0 cites·10 claims
- 3241US10793544B2Disubstituted and trisubstituted 1,2,3-triazoles as Wnt inhibitorsUNIV TEXAS·Filed 2017·Granted Oct 6, 2020·0 cites·19 claims
- 3341US10420758B2Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereofUNIV TEXAS·Filed 2016·Granted Sep 24, 2019·0 cites·17 claims
- 3437US2001024798A1Biomimetic combinatorial synthesisFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chuo Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →